Weaponized “Misinformation” to Bury Safety Concerns: The Case of RSV Monoclonal Antibodies
A recent critique raises a number of claims regarding my article. This response addresses the substantive points directly, focusing solely on the evidence. When evaluating new interventions for healthy newborns, presenting the full safety record is not optional; it is a fundamental obligation.











